Evaluation of postoperative mobility and nutrition in the Enhanced Recovery after Surgery (ERAS) - Pathway and the influence of patient-centered consultation on ERAS-Goals in elective bowel surgery - a randomized pilotstudy

Organizational Data

DRKS-ID:
DRKS00027863
Recruitment Status:
Recruiting complete, study complete
Date of registration in DRKS:
2022-02-25
Last update in DRKS:
2023-11-03
Registration type:
Prospective

Acronym/abbreviation of the study

MINT-ERAS

URL of the study

No Entry

Brief summary in lay language

The ERAS ("enhanced recovery after surgery") - pathway describes interprofessional management surrounding the surgery, which should make possible a fast recovery of the patient. ERAS includes patient-centered, evidence-based and procedure-specific treatment pathways designed to prevent organ malfunctions and prevent complications. Thus, after surgical intervention, physiological balance is rapidly restored postoperatively, which accelerates the entire recovery process of patients. The successful implementation of the ERAS treatment pathways has a reduced overall complication rate of up to half and a median two to three days shorter duration of inpatient stay compared to classic perioperative management in bowel operations. Early postoperative nutrition from the day of surgery, daily protein supplementation (600 kcal) to recompensate the postoperative catabolic phase and immediate, comprehensive mobilization after surgery (cumulatively six hours out of bed from post-op day 1) are essential success factors of the ERAS program. At the same time, the ERAS-goals in the areas food/protein intake and rapid, complete mobilization are big challenges to achieve, even in ERAS Centers of Excellence. Furthermore, ERAS-studys which investigate food intake and mobilization has so far largely recorded self-assessments of patients or nursing staff and no objective data. Last but not least, the goals set in the ERAS path are also predominantly general and not realistic for every patient; here a component of personalization and thus better motivation to achieve these goals is missing. Motivational interviewing is a well-known and evidence-based type of patient-centered conversation that was first described and developed by Miller and Rollnick in 1991. In the meantime, numerous studies have shown that motivational interviewing is an effective methodology suitable for everyday use in the context of family doctor and addiction medicine in the treatment of substance dependence, lifestyle and chronic diseases. Largely new and still little studied is the application in the context of complex abdominal surgery for optimal preparation and support of the postoperative recovery process. We hope to achieve a stronger implementation of the ERAS criteria in terms of postoperative exercise and nutrition through the motivational interviewing intervention. In addition, we see great potential in Motivational Interviewing as a basic attitude and ability of patient-centered and yet effective medicine, which should also be learnable and implementable in the dynamic inpatient everyday life of a university hospital. The aim of this randomized pilot study is to first examine whether these novel, patient-centered consultation and intervention can be implemented in an inpatient context for patients and the treatment team and whether they are accepted and positively evaluated by patients. By randomization, it will be examined exploratively whether patients who have participated in preoperative and postoperative intervention with motivational interviewing technique have significantly better achievement of the ERAS goals compared to the control group (patients whose conversations/visits take place without Motivational Interviewing elements). The focus is on a stronger achievement of early mobilization and sufficient nutrition, as defined as goals in the ERAS bowel-path in general and in the clinic-path of the Surgical Clinic: Mobilization from bed: 2h on the day of surgery, 6h from post-op day 1 to discharge; Nutrition: Protein supplementation of 600 kcal per day (e.g. 3x protein shakes with meals). Mobility is measured by three motion sensors (Garmin Vivosmart 4, Move 4 and ECG Move 4 of the company Movisens). The nutrition is tracked by photo documentation of the food ingested and the protein shakes. In addition, the objectively obtained data can also be used to draw conclusions as to whether the general target variables defined in the ERAS program are realistic for the vast majority of patients or whether individual target specifications should be individually adapted in order to be able to have a motivating effect.

Brief summary in scientific language

Perioperative management through ERAS ("enhanced recovery after surgery") means interprofessional, patient-centered work according to evidence-based, procedure-specific treatment pathways designed to prevent organ malfunctions and prevent complications. Thus, after surgical intervention, physiological homeostasis is rapidly restored postoperatively, which accelerates the entire recovery process of patients. The successful implementation of the ERAS treatment pathways has a reduced overall complication rate of up to half and a median two to three days shorter duration of inpatient stay compared to classic perioperative management in bowel operations. Early postoperative nutrition from the day of surgery, daily protein supplementation (600 kcal) to recompensate the postoperative catabolic phase and immediate, comprehensive mobilization after surgery (cumulatively six hours out of bed from post-op day 1) are essential success factors of the ERAS program. At the same time, the areas of food/protein intake and rapid, complete mobilization are the biggest challenges for achieving a high level of target compliance, even in ERAS Centers of Excellence. Furthermore, the ERAS compliance audit on food intake and mobilization scope has so far largely recorded self-assessments of patients or nursing staff and no objective data. Last but not least, the goals set in the ERAS path are also predominantly general and not realistic for every patient; here a component of personalization and thus better motivation to achieve these goals is missing. Motivational interviewing is a well-known and evidence-based type of patient-centered conversation that was first described and developed by Miller and Rollnick in 1991. In the meantime, numerous studies have shown that motivational interviewing is an effective methodology suitable for everyday use in the context of family doctor and addiction medicine in the treatment of substance dependence, lifestyle and chronic diseases. Largely new and still little studied is the application in the context of complex abdominal surgery for optimal preparation and support of the postoperative recovery process. We hope to achieve a stronger implementation of the ERAS criteria in terms of postoperative exercise and nutrition through the motivational interviewing intervention. In addition, we see great potential in MI as a basic attitude and ability of patient-centered and yet effective medicine, which should also be learnable and implementable in the dynamic inpatient everyday life of a university hospital. The MI-consultations in our study are carried out by two doctoral students with MI-Basic-Course certificate (+ Supervision and MITI evaluation by experienced MI coaches). The aim of this randomized pilot study is to first examine whether these novel, patient-centered consultation and intervention can be implemented in an inpatient context for patients and the treatment team and whether they are accepted and positively evaluated by patients. By randomization, it will be examined exploratively whether patients who have participated in preoperative and postoperative intervention with motivational interviewing technique have a significantly higher compliance with regard to the ERAS goals compared to the control group (patients whose conversations/visits take place without MI elements). The focus is on a stronger achievement of early mobilization and sufficient nutrition, as defined as goals in the ERAS bowel-path in general and in the clinic-path of the Surgical Clinic: Mobilization from bed: 2h on the day of surgery, 6h from post-op day 1 to discharge; Nutrition: Protein supplementation of 600 kcal per day (e.g. 3x protein shakes with meals). Mobility is measured by three motion sensors (Garmin Vivosmart 4, Move 4 and ECG Move 4 of the company Movisens). The nutrition is tracked by photo documentation of the food ingested and the protein shakes. In addition, the objectively obtained data can also be used to draw conclusions as to whether the general target variables defined in the ERAS program are realistic for the vast majority of patients or whether individual target specifications should be individually adapted in order to be able to have a motivating effect. Another goal of the pilot-study is to evaluate the novel study-design and generate first data to the endpoints. The findings of the pilot-study should be used to check the feasability and rationale of a multicentered follow-up study with an application for third-party funds.

Health condition or problem studied

Free text:
Included are patients with elecitve colorectal surgery, most common reasons: Bowel/Sigma/Rectum Carcinoma; stoma-relocation; chronic inflammatory bowel diseases (M. Crohn & C. Ulcerosa)
Healthy volunteers:
No Entry

Interventions, Observational Groups

Arm 1:
technical instructions + daily ERAS-SOC (standard of care) + consultations with motivational interviewing (1x preoperative (+-20min) and 4x postoperative (one time per day after surgery, +-15 min -> individual, between 17.30 and 20.00))
Arm 2:
technical instructions + daily ERAS-SOC (standard of care) + visits/conversations without motivational interviewing (same time/frequency like in the intervention group), among other things for charging the sensors & documentation

Endpoints

Primary outcome:
Comparison of the groups as to whether motivational interviewing can improve the achievement of the ERAS-goals with regard to postoperative mobilization and nutrition (from op day to third postoperative day) Mobilization parameter: Steps & activity parameters: lie, sit, stand, walk Nutrition parameter: Kcal Uptake via food & proteinshakes
Secondary outcome:
„Scientific-Feasibility“: Evaluation of the postoperative food-intake and mobilization in general with objective data exploration meaningfullness of „universelly“ (not-personalized) ERAS-goals Validity and Fidelity of the MI-Intervention (Patient perspective: REM-Questionnaire; Supervision (qualitative) and objective, quantiative Evaluation with Motivational Interviewing Treatment Integrity - MITI); “contamination” of the control group (quantitative by written questioning after the study, if they think that they were in the control or experimental group - examination of blinding; REM - Questionnaire; „Process-Feasibility“: recruitment-rate (percentage included participants after screening); acceptance und compliance of the patients in terms of technical equipment (percentage utilization of the sensors & photo-documentation); evaluation of the MI-Consulations by patients (Rating Scales for the Assessment of Empathic Communication in Medical Interviews - REM-questionnaire); integration MI-intervention in everyday life of the clinic (quantitative: Duration of MI-Consultations; qualitative: clinic-setting, interviewer-perspective) Questionnaires: IPAQ - physical activity (pre-op) PG-SGA - nutrition (pre-op) GSE - Self-efficacy (pre-op, post op day 3) PAM13-D - Patientactivation (pre-op, post op day 3) PEQ - Patient-Satisfaction (post-op day 30) HADS - Anxiety/Depression (pre-op, post op day 3) QoR-15 - Quality of Recovery (pre-op, post op day 1 & 3) Barthel-Index (pre-op, post op day 3) REM - felt empathy (post-op day 3) further raised parameters: ERAS-Compliance Variables (EIAS - database) apparative with sensors: kcal-consumption, MET-Level, heartfrequency, HRV (Baevskii-Stress-Index) daily pain, nausea (NRS-scale) op-duration, duration of hospitalization subjective assessment (patients) concerncing activity and food-intake for comparison with objective data usage of MI-elements from self-created "guide" (checked by supervision) for our study setting

Study Design

Purpose:
Supportive care
Allocation:
Randomized controlled study
Control:
  • Active control (effective treatment of control group)
Phase:
N/A
Study type:
Interventional
Mechanism of allocation concealment:
No Entry
Blinding:
Yes
Assignment:
Parallel
Sequence generation:
No Entry
Who is blinded:
  • Patient/subject

Recruitment

Recruitment Status:
Recruiting complete, study complete
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Germany
Number of study centers:
Monocenter study
Recruitment location(s):
  • Medical center Universitätsklinik Mannheim

Recruitment period and number of participants

Planned study start date:
2022-03-01
Actual study start date:
2022-03-08
Planned study completion date:
No Entry
Actual Study Completion Date:
2022-08-08
Target Sample Size:
60
Final Sample Size:
60

Inclusion Criteria

Sex:
All
Minimum Age:
18 Years
Maximum Age:
no maximum age
Additional Inclusion Criteria:
• patients with elective bowel surgery • adults (≥18 years) • agreement for therapy according to ERAS criteria • ability to understand the character and the individual consequences of the study. Also the acceptance and willingness to follow the requirements of the study protocol (carrying sensors, photo-documentation) • signed declaration of consent after study instructions • Barthel Index concerning mobility at least 10 points: "walks with help of one person (verbal or physical) > 50 yards"

Exclusion Criteria

• language barriers (valid declaration of consent is not possible, misunderstanding of the documentation) • hearing problems, which can not be compensated and make a fluent conversation difficult • mental conditions, which make a MI-consultation impossible • confinement to bed (Barthel mobility < 10 points) • PEG or parenteral nutrition • expected non-compliance • cardial devices: CCM, ICD, CRT, because of the interaction risk with mobility-sensors • participation on another study with the same primary endpoint (mobility or nutrition)

Addresses

Primary Sponsor

Address:
Universitätsklinikum Mannheim
Theodor-Kutzer-Ufer 1-3
68167 Mannheim
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.umm.de
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
Medizinische Fakultät Mannheim der Universität Heidelberg Chirurgische Klinik Universitätsmedizin Mannheim
PD Dr. med. Florian Herrle
Theodor-Kutzer-Ufer 1-3
68167 Mannheim
Germany
Telephone:
0621-383 1501
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.umm.de/1863/

Contact for Public Queries

Address:
Medizinische Fakultät Mannheim der Universität Heidelberg Chirurgische Klinik Universitätsmedizin Mannheim
PD Dr. med. Florian Herrle
Theodor-Kutzer-Ufer 1-3
68167 Mannheim
Germany
Telephone:
0621-383 1501
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.umm.de/1863/

Principal Investigator

Address:
Medizinische Fakultät Mannheim der Universität Heidelberg Chirurgische Klinik Universitätsmedizin Mannheim
PD Dr. med. Florian Herrle
Theodor-Kutzer-Ufer 1-3
68167 Mannheim
Germany
Telephone:
0621-383 1501
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.umm.de/1863/

Sources of Monetary or Material Support

Institutional budget, no external funding (budget of sponsor/PI)

Address:
Universitätsklinikum Mannheim
Theodor-Kutzer-Ufer 1-3
68167 Mannheim
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.umm.de

Ethics Committee

Address Ethics Committee

Address:
Ethik-Kommission II der Universität Heidelberg, Medizinische Fakultät Mannheim
Theodor-Kutzer-Ufer 1-3
68167 Mannheim
Germany
Telephone:
+49-621-38371770
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.umm.uni-heidelberg.de/forschung/ethikkommission-ii/

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2021-12-31
Ethics committee number:
2021-698-AF 5
Vote of the Ethics Committee:
Approved
Date of the vote:
2022-02-10

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
UTN (Universal Trial Number):
No Entry
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
No
IPD Sharing Plan:
No Entry

Study protocol and other study documents

Study protocols:
No Entry
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Planned publication:
No Entry
Publikationen/Studienergebnisse:
No Entry
Date of first publication of study results:
No Entry
DRKS entry published for the first time with results:
No Entry

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry